Skip to main content

Topic

Biosimilars

856 published works

  1. Health Industry Washington Watch

    FDA User Fee Program for Biosimilar and Interchangeable Biological Product Applications

    By Debra A. McCurdy

    The Food and Drug Administration (FDA) published a notice on May 10, 2011 seeking comments on its upcoming user fee program for biosimilar and interchangeable biological product (351(k)) applications. The…

  2. Health Industry Washington Watch

    FDA Seeks Stakeholder Participation in ACA Biosimilars User Fee Meetings

    By Debra A. McCurdy

    On December 8, 2010, the Food and Drug Administration (FDA) published a notice requesting that stakeholders - particularly patient and consumer advocacy groups, health care professionals, and scientific and academic experts…

  3. Health Care and Life Sciences

    FDA Announces Much Anticipated Public Hearing on Biosimilars

    By Sheppard Mullin

    By Deborah M. Shelton Having had the opportunity to analyze the biosimilars provisions of the new health care law enacted this past March, stakeholders have at long last the chance…

  4. Life Sciences Legal Update

    FDA to Hold Public Meeting on ACA Biosimilars Pathway – November 2-3, 2010

    By Debra A. McCurdy

    Today the FDA published a notice announcing public hearings on November 2 and 3, 2010 on implementation of the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), which…

  5. Health Industry Washington Watch

    FDA to Hold Public Meeting on ACA Biosimilars Pathway – November 2-3, 2010

    By Debra A. McCurdy

    Today the FDA published a notice announcing public hearings on November 2 and 3, 2010 on implementation of the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), which…

  6. Chicago IP Litigation

    Tribune on Patents

    By R. David Donoghue

    The Chicago Tribune has had a few IP-related articles this week. First, the Tribune reported - click here for the story -- that the House is about to take up…